Nicholas Stoyer

In May of 1999, Nicholas Stoyer was diagnosed with a medulloblastoma (PNET) brain tumor. He was 5 ½ years young when he began having headaches and episodes of vomiting. A CT Scan was ordered and the results were a brain tumor. Nick’s mother was told to take him immediately to the emergency room at the Children’s Hospital. Two days later surgery was performed to remove the tumor. After six weeks of recovery from surgery, Nicholas was put on a protocol for radiation and chemotherapy. Nicholas received 30 radiation treatments to his cranium and spine. He received an additional five radiation treatments to his pituitary area of the forehead. During the radiation treatments, Nick also received 35 doses of one of the chemotherapy drugs. After another 6 weeks of recovery, the protocol was set to receive three different chemotherapy drugs over a 12 to 14 month period. After four months of chemotherapy, Nick’s mother, Robyn, was totally disillusioned with conventional medicine, and its approach to the treatment of her son. She was witnessing first hand the invasive and harmful side effects of such treatment.

Through research she discovered that the success conventional medicine claimed with medulloblastoma, also came with considerable loss of quality of life to the patient and often death. Robyn had researched antineoplaston therapy. She contacted the Burzynski Clinic to see if she could have Nicholas evaluated and accepted for antineoplaston treatment. Robyn contacted Angel Flights and they flew to Houston, Texas. Dr. Burzynski and other staff oncologists evaluated Nicholas and he was accepted for antineoplaston treatment.
Robyn made the decision to stop the chemotherapy, against the guidance of her conventional oncologist in Atlanta, Georgia and began antineoplaston treatment immediately.

Since February of 2001, Nicholas has been in remission. He has made up for lost time from his childhood by being in cub scouts, karate, bicycling, golf, basketball, paintball, swimming, playing with children and excelling in school.

Nicholas’ neurosurgeon keeps a check on him with regular MRI’s and once said, “I cannot believe how well Nicholas is doing!”
It is our highest hope that antineoplaston therapy at the Burzynski Clinic becomes the treatment of choice for the millions of people diagnosed with cancer.